BackRafarma Pharmaceuticals Overview

Rafarma Pharmaceuticals Current Cash

Latest current cash for RAFA: $63K.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$63000.00

Peer trimmed avg / median

Loading

Rafarma Pharmaceuticals Current Cash History

Loading

Rafarma Pharmaceuticals vs. peers: Current Cash Comparison

Loading

Rafarma Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Rafarma Pharmaceuticals (RAFA) FAQ

The latest current cash for RAFA is $63K as of September 2026. Investors often review this figure alongside Rafarma Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

A current cash figure of $63K for RAFA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting RAFA's current cash ($63K), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.